Proteogenomics: DNA-to-Peptide Neoantigen Explorer |…

What Proteogenomics Is

Proteogenomics is a field that integrates genomics and proteomics to study how genetic variations impact protein structure and function. In the context of cancer, it focuses on identifying neoantigens—proteins derived from mutated genes that can be recognized by the immune system.

The process begins with a point mutation in DNA, which then undergoes transcription into mRNA and translation into a peptide. This pathway is crucial for understanding how genetic alterations can lead to the development of cancer.

How Proteogenomics Works

The process starts with introducing a mutated codon in a gene, which then transcribes into mRNA. During translation, this mRNA is translated into a peptide sequence. The resulting peptide may differ from the wild-type version due to the mutation.

Whether this variant peptide can be recognized by the immune system as an antigen depends on its stability and ability to bind to MHC molecules for presentation.

live demo · related simulation● LIVE

Why It Matters

Identifying neoantigens is critical in cancer immunotherapy, where the goal is to stimulate the body's immune response against tumor cells. By understanding how mutations lead to neoantigen formation, researchers can develop more effective vaccines and therapies.

Moreover, proteogenomics helps in personalizing treatment strategies by identifying unique neoantigens present only in a patient’s cancer.

Real-World Applications

In clinical settings, proteogenomic analysis can help predict which patients are most likely to benefit from immunotherapy. This information is crucial for tailoring treatment plans and improving outcomes.

Additionally, it aids in the development of new drugs that target specific neoantigens, potentially leading to more precise and effective cancer treatments.

Frequently asked questions

What are neoantigens?

Neoantigens are proteins derived from mutated genes that can be recognized by the immune system. They play a key role in immunotherapy for cancer treatment.

How does proteogenomics help in cancer research?

Proteogenomics helps identify neoantigens, which can be targeted to stimulate an immune response against tumors. This knowledge is vital for developing personalized cancer treatments and therapies.

Why is MHC presentation important in this process?

MHC (Major Histocompatibility Complex) molecules present peptides on the surface of cells, allowing T-cells to recognize and attack them. The ability of a peptide to bind to MHC determines whether it can be presented as an antigen.

Can all mutations lead to neoantigens?

Not all mutations result in neoantigens. Only those that significantly alter the amino acid sequence and are stable enough to be recognized by T-cells can become neoantigens, making proteogenomics a selective process.

Try it live

Everything above runs in your browser — open Proteogenomics: DNA-to-Peptide Neoantigen Explorer and change the parameters while it is running. Nothing is installed, nothing is uploaded, the whole model lives in one tab.

▶ Open Proteogenomics: DNA-to-Peptide Neoantigen Explorer simulation